Healthcare Transformation Executive Dr. Liz Kwo Joins the ChroniSense Medical Board of Directors

Yokneam Illit, Israel, April 25 – ChroniSense Medical welcomes Liz Kwo, MD, MBA, MPH to its Board of Directors as the company’s first independent board director. Dr. Kwo brings extensive clinical, entrepreneurial and leadership experience to the ChroniSense board, as founder and executive of several successful healthcare companies. Currently, Dr. Kwo serves as Chief Medical Officer of Everly Health, a diagnostics-driven consumer health company that encompasses the nationally distributed Everlywell at-home tests among other B2B and B2C healthcare solutions. Prior to joining Everly Health this year, Dr. Kwo was Deputy Chief Clinical Officer at Anthem, a leading health insurance company, and was CEO & Co-Founder of InfiniteMD, a second opinion telemedicine company. Earlier in her career, Dr. Kwo founded multiple venture-backed technology companies, after earning a B.A. in Human Biology from Stanford University, M.D. from Harvard Medical School, M.B.A. from Harvard Business School, and an M.P.H. from Harvard TH Chan School of Public Health. Dr. Kwo also serves on the Asensus Surgical Board of Directors in the Compensation Committee (NYSE American: ASXC) and recently held a board seat at Flexion Therapeutics (NASDQ: FLXN).

“We are thrilled to have Dr. Kwo join the ChroniSense Medical Board of Directors, where her perspectives as a healthcare entrepreneur and physician will help to advance our mission of empowering people living with chronic diseases to manage their health at home,” said Bridget Ross, CEO of ChroniSense Medical. “With our Polso™ multi-parameter remote monitoring platform heading toward initial market release this year, Dr. Kwo’s sharp insights are particularly valuable to ChroniSense at this exciting time for our company.”

Serving with Dr. Kwo on ChroniSense Medical’s Board of Directors are Ilan Neugarten, a deeply experienced MedTech leader and investor and Executive Chairman of Rainbow Medical, and Yossi Cohen, the Rainbow Medical CFO with an extensive MedTech deal history. Rainbow Medical, an innovation and investment house powering ChroniSense’s development of the Polso™ platform was founded by Yossi Gross, a world-renowned entrepreneur with over 30 companies and 800+ filed patents to his name.